GlassScriptPhysician profile
Andrew-Paul Deeb
NPI 1790139806
$2,514.72
in general payments reported to CMS, 2019-2025
15 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $1,619 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173 · Travel and Lodging: $966 · Consulting Fee: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.40 |
| Travel and Lodging | $966.32 |
| Consulting Fee | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,490.15 | 2024-2025 | Gelpoint Path Transanal Access Platform |
| Medtronic, INC. | $235.41 | 2024-2025 | Signia, Interstim |
| Guard Medical INC. | $170.20 | 2023 | Npseal Large, Npseal (5), Npseal Medium |
| Organogenesis INC. | $156.06 | 2025 | Puraply Wound Matrix |
| Boston Scientific Corporation | $127.37 | 2024 | |
| Conmed Corporation | $93.39 | 2024 | Airseal |
| Integra Lifesciences Corporation | $91.33 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Intuitive Surgical, INC. | $28.98 | 2024 | |
| Solventum Corporation | $24.50 | 2025 | 3m Cavilon, Prevena, V.A.C. Veraflo |
| Octapharma USA, INC. | $19.92 | 2025 | Fibryga |
| Mimedx Group, INC. | $17.98 | 2025 | |
| Teleflex LLC | $17.30 | 2024 | Titan Sgs |
| Convatec INC. | $16.27 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $14.08 | 2025 | |
| Kerecis Limited | $11.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew-Paul Deeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.